Avalo Therapeutics, Inc. (AVTX) announced the immediate appointment of Mittie Doyle as the Chief Medical Officer on Tuesday.
With over 20 years of experience in the pharmaceutical/biotech industry, Mittie Doyle is a research physician with various leadership positions in clinical development.
Mittie transitions to Avalo from Aro Biotherapeutics, where she served as Chief Medical Officer since 2021.
Following Doyle's appointment, Avalo's Board approved granting a non-qualified stock option to her employment agreement, enabling her to purchase 234,000 shares of its common stock.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.